AI-generated summary
The authors describe a planned double-blind randomized trial protocol testing 830-nanometer light therapy at three energy densities in 136 volunteers with diabetic foot ulcers, compared with a 904-nanometer control. No results are reported, as the study is a protocol and outcomes are yet to be measured. The authors state the findings may inform effective parameters and feasibility of this treatment in clinical practice.
- Participants
- 136
- Who or what was studied
- Volunteers with diabetic foot ulcers (planned enrollment of 136, randomized into four groups)
- Wavelengths
- 830, 904 nm
- Limits stated in the abstract
- This is a trial protocol only, so no outcome data are reported and the planned results are not yet available.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm, 904 nm
- Power
- 30 mW, 70 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Nanometer, Fluence, Dose, Control group, Depression, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.